ChengDa Pharmaceuticals Co. Ltd.

301201 • SHE

¥36.77-¥0.81 (2.16%)

Estimate

EPS

-0.02

Beta

-0.23

Growth

Revenue, YoY

43.51%

Net income, YoY

110.22%

FCF, YoY

72.81%

Dividends

Dividend yield

0.54%

Annual payout

¥0.20

Next ex. div date

July 15, 27

Div.rating

About the company

Ticker

301201

ISIN

CNE100005766

Country

China

Sector (GICS)

Healthcare

ChengDa Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates, active pharmaceutical ingredients, and food and feed additives in China and internationally. It offers process research and development, process optimization, quality and stability research, customized production and other services for pharmaceutical intermediates and APIs; and food and feed additives, such as L-carnitine and L-carnitine tartrate. The company also provides bulk drug products, including urogenital, nervous system, blood and hematopoietic organs, musculoskeletal system, digestive tract and metabolism, antineoplastic and immunomodulators; and pharmaceutical intermediates comprising drug intermediates for blood and hematopoietic organs, drug intermediates in digestive tract and metabolism, and nervous system drug intermediates. ChengDa Pharmaceuticals Co., Ltd. was founded in 1980 and is based in Jiaxing, China.

Frequently asked questions

What sector does ChengDa Pharmaceuticals Co. Ltd. (301201) operate in?

ChengDa Pharmaceuticals Co. Ltd. belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is ChengDa Pharmaceuticals Co. Ltd. (301201) current stock price?

As of the latest data, ChengDa Pharmaceuticals Co. Ltd. stock price is CN¥36.77, with a previous close of CN¥37.58. ChengDa Pharmaceuticals Co. Ltd. lost -CN¥0.81 in the last trading session, representing a -2.16% loss.

What is ChengDa Pharmaceuticals Co. Ltd. (301201) current market capitalization?

ChengDa Pharmaceuticals Co. Ltd. market cap is approximately 5.69 billion.

What is ChengDa Pharmaceuticals Co. Ltd. (301201) Earnings Per Share (EPS)?

The trailing EPS is -CN¥0.02.

Does ChengDa Pharmaceuticals Co. Ltd. (301201) pay dividends?

Yes. ChengDa Pharmaceuticals Co. Ltd. pays annual dividends with an annualized yield of 0.54% and an estimated annual payout of CN¥0.20 per share.

When is the next ex-dividend date for ChengDa Pharmaceuticals Co. Ltd. (301201)?

The next ex-dividend date is scheduled for July 15, 2027.

What is ChengDa Pharmaceuticals Co. Ltd. (301201) beta (volatility) score?

ChengDa Pharmaceuticals Co. Ltd. has a beta of -0.230, indicating lower volatility than the overall market.